- Orally Bioavailableβ-Lactam/β-Lactamase Inhibitor Combination for Biodefense and Public Health
Contract Overview
Contract Amount: $48,577,807 ($48.6M)
Contractor: Venatorx Pharmaceuticals Inc
Awarding Agency: Department of Health and Human Services
Start Date: 2016-09-19
End Date: 2026-03-31
Contract Duration: 3,480 days
Daily Burn Rate: $14.0K/day
Official Description: IGF::OT::IGF - ORALLY BIOAVAILABLEβ-LACTAM/β-LACTAMASE INHIBITOR COMBINATION FOR BIODEFENSE AND PUBLIC HEALTH.
Place of Performance
Location: Pennsylvania, 19355